An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus - Related Studies

An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus

This study has been completed.

Study NCT00135330. Last updated on July 23, 2008. Information provided by Amylin Pharmaceuticals, Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Diabetes Mellitus, Type 2

2	Additional conditions recognized in this trial
		Diabetes Mellitus

3	More general conditions related to this trial
		Endocrine System Diseases
		Glucose Metabolism Disorders
		Metabolic Diseases

4	Interventions listed in this trial
		exenatide
		rosiglitazone

5	More general drug interventions related to this trial
		Hypoglycemic Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

6	Sponsors listed in this trial
		Amylin Pharmaceuticals, Inc.
		Eli Lilly and Company